Tag: Pharmaceutical research and development
Novo Nordisk’s Next-Generation Obesity Treatment Falls Short in Key Trial
Novo Nordisk, a prominent player in the pharmaceutical industry, recently faced a setback with its next-generation obesity treatment, CagriSema. The highly anticipated treatment showed...
Exploring R&D Strategies of Amgen, Biogen, and Takeda for Challenging Targets
Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in...
Weight Loss Drug Prices and Patent Corrections: Pharmalittle News
Title: Weight Loss Drug Pricing Strategies and Legislative Impact in the Pharmaceutical IndustryAs we approach the end of another work week, it's time to...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
